Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C45H58N10O13 |
Molecular Weight | 947.0012 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@@H]1NC(=O)[C@@H]2CNC(=O)C[C@H](NC(=O)[C@H](CC(=O)N[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NC(C)=O)NC1=O)C(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)N2
InChI
InChIKey=NGCNKEZHGRXHNL-WVWQGFTISA-N
InChI=1S/C45H58N10O13/c1-21(2)13-27-39(62)53-31(17-35(59)55-45-36(48-22(3)57)38(61)37(60)33(20-56)68-45)43(66)52-30-16-34(58)47-19-32(44(67)49-27)54-40(63)28(14-23-9-5-4-6-10-23)50-41(64)29(51-42(30)65)15-24-18-46-26-12-8-7-11-25(24)26/h4-12,18,21,27-33,36-38,45-46,56,60-61H,13-17,19-20H2,1-3H3,(H,47,58)(H,48,57)(H,49,67)(H,50,64)(H,51,65)(H,52,66)(H,53,62)(H,54,63)(H,55,59)/t27-,28-,29-,30-,31-,32-,33+,36+,37+,38+,45+/m0/s1
Molecular Formula | C45H58N10O13 |
Molecular Weight | 947.0012 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Menarini was developing oral nepadutant (MEN 11420), a potent and selective tachykinin neurokinin-2 receptor antagonist, for the treatment of infant colic. Nepadutant has been used in trials studying the treatment of colic, infantile colic, and infantile functional gastrointestinal disorders. MEN 11420 is a glycosylated derivative of the potent, selective, conformationally-constrained tachykinin NK2 receptor antagonist MEN 10627. MEN 11420 competitively bound with high affinity to the human NK2 receptor stably transfected in CHO cells, displacing radiolabelled [125I]-neurokinin A and [3H]-SR 48968 with Ki values of 2.5+/-0.7 nM (n = 6) and 2.6+/-0.4 nM (n = 3), respectively.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist. | 1998 Jan |
|
Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models. | 2001 Oct |
|
Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor. | 2005 Jun 1 |
|
MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist. | 2006 Nov 7 |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00655083
Infantile Colic: 0.1 - 0.5 mg/Kg as one single oral dose divided in three age strata (from 6 to 24 weeks old)
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9484857
Nepadutant (MEN 11420) competitively bound with high affinity to the human NK2 receptor stably transfected in CHO cells, displacing radiolabelled [125I]-neurokinin A and [3H]-SR 48968 with Ki values of 2.5±0.7 nM (n=6) and 2.6±0.4 nM (n=3), respectively. In the rabbit isolated pulmonary artery and rat urinary bladder MEN 11420 potently and competitively antagonized tachykinin NK2 receptor-mediated contractions (pKB=8.6±0.07, n=10, and 9.0±0.04, n=12; Schild plot slope=−1.06 (95% c.l.=−1.3; −0.8) and −1.17 (95% c.l.=−1.3; −1.0), respectively). MEN 11420 produced an insurmountable antagonism at NK2 receptors in the hamster trachea and mouse urinary bladder. However, in both preparations, the effect of MEN 11420 was reverted by washout and an apparent pKB of 10.2±0.14, n= 9, and 9.8±0.15, n=9, was calculated in the hamster trachea and mouse urinary bladder, respectively.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:16:38 GMT 2023
by
admin
on
Fri Dec 15 16:16:38 GMT 2023
|
Record UNII |
XW59TYL1XH
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29712
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
XW59TYL1XH
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY | |||
|
CHEMBL1908318
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY | |||
|
SUB09196MIG
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY | |||
|
DB12538
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY | |||
|
C84001
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY | |||
|
183747-35-5
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY | |||
|
DTXSID801032036
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY | |||
|
100000084173
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY | |||
|
7719
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY | |||
|
9876321
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY | |||
|
Nepadutant
Created by
admin on Fri Dec 15 16:16:38 GMT 2023 , Edited by admin on Fri Dec 15 16:16:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|